Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published September 16, 2020

Calvin Scott Diethylpropion Tablets Recall: Repackaging Without Stability Studies

Calvin Scott recalls 25mg Diethylpropion tablets (Rx only) repackaged without stability testing. Affected lots expire by Dec 2020 or later. Consumers should contact manufacturer for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0009-2021DrugCalvin Scott ›
Take action

Contact the company

Recalling firmCalvin Scott & Company, Inc.209 Eubank Blvd Ne · Albuquerque, NM 87123-2745
✎ GovInfoNow plain-language explainer

Calvin Scott is recalling 25mg Diethylpropion tablets that were repackaged without stability studies. This could lead to product degradation over time, potentially affecting safety and effectiveness. Read more at govinfonow.com/recall/36772-calvin-scott-diethylpropion-tablets-recall-repackaging-without-stability-studies.

Source Summary by GovInfoNow · govinfonow.com/recall/36772-calvin-scott-diethylpropion-tablets-recall-repackaging-without-stability-studies · Updated October 4, 2026 · FDA enforcement record: FDA #D-0009-2021

Cite this page

“Calvin Scott Diethylpropion Tablets Recall: Repackaging Without Stability Studies.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36772-calvin-scott-diethylpropion-tablets-recall-repackaging-without-stability-studies. Based on FDA recall #D-0009-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2021%22&limit=1).

The FDA announced on Sept. 16, 2020, that Calvin Scott & Company, Inc. voluntarily recalled Diethylpropion, 25 mg tablets due to current good manufacturing practice deviations involving repackaging without stability studies. The recall affects specific lots distributed to physician consignees in five states.

How to tell if you have it

  • Brand: Calvin Scott
  • Product: Diethylpropion, 25 mg tablets
  • NDC: 00527-1475-01
  • Lot codes: CS19311, CS19337 (Exp 12/20); CS20018B, CS20019, CS20037, CS20075, CS20076, CS20112, CS20169 (Exp 8/21); CS20168 (Exp 12/21); CS20199 (Exp 5/22); CS20243 (Exp 7/22)
  • Manufacturer: Lannett Company
  • Distribution states: CA, ID, IL, OK, RI

The hazard

According to the FDA, the drug products were repackaged into pouches without supporting stability studies. The agency classified this violation as a Class II recall.

Context

GovInfoNow's records show Calvin Scott & Company, Inc. has two other recalls on record since July 27, 2020. On Jan. 15, 2021, the company recalled Benzphetamine Tablets due to a label mix-up risk involving Benzonatate capsules. On July 27, 2020, Calvin Scott Phentermine Capsules were recalled for light sensitivity risks associated with transparent pouches. Other recent recalls of similar products include Harvard Drug Group Omega-3 Capsules Recall (April 9, 2026), Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026), and B Braun Dextrose Injection Recall (April 2, 2026).

How to tell if you have this one

Check the lot numbers on the packaging: CS19311, CS19337 (expiring Dec 2020), CS20018B through CS20243 (expiring by May 2022). These tablets are prescription-only.

  • Brand
    Calvin Scott
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI
Recall numberProduct, codes & lots
D-0009-2021Diethylpropion, 25 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1475-01; Lot #: CS19311, CS19337, Exp 12/20; CS20018B, CS20019, CS20037, CS20075, CS20076, CS20112, CS20169, Exp 8/21; CS20168, Exp 12/21; CS20199, Exp 5/22; CS20243, Exp 7/22
D-0010-2021Diethylpropion, 75 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1477-01; Lot #: CS19192, CS19226, CS19263, Exp 10/20; CS19300, Exp 7/21; CS19338, Exp 8/21; CS20034, Exp 10/21; CS20077, Exp 1/22, CS20165, CS20241, Exp 4/22
D-0011-2021Phentermine, 30 mg capsules, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-0597-10; Lot #: CS19309, CS20098, Exp 12/21
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Look for specific lot numbers on the packaging: CS19311, CS19337 (expiring Dec 2020), CS20018B through CS20243 (expiring by May 2022).

Where it went and when

Where it was distributed

Distributed in 5 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: yesIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: yesRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: yesOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Idaho, Illinois, Oklahoma, Rhode Island.

Recall timeline

FDA terminated this recall 3.6 years after the firm started it.

1. Firm started the recall: Sep 16, 202012. FDA classified it Class II: Oct 2, 202023. Published in FDA’s Enforcement Report: Oct 14, 202034. FDA terminated the recall: Apr 22, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0009-2021 (September 16, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0009-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA